The therapeutic efficacy of sulfanilamide in clinical and experimental infections due to Beta-hemolytic streptococci and certain other bacteria seems to be established. However, the mechanism underlying the action of the drug remains open to conjecture. Levaditi and Vaisman (1935) suggested that the effectiveness of the drug is due to interference with formation of bacterial capsules. Neither Colebrook and his associates (1936) nor Long and Bliss (1937a) were able to confirm this. Attention was focussed upon the possible effect of the drug on phagocytosis, when Long and Bliss (1937a) found an unusual increase in phagocytosis of streptococci by both polymorphonuclear and mononuclear leucocytes in peritoneal smears from mice recovering under sulfanilamide therapy. Mellon, Gross and Cooper (1937) studied histological sections of subcutaneous streptococcus lesions in treated and untreated guinea pigs, and were unable to demonstrate that phagocytosis played a primary role in the curative process. Weinberg, Mellon, and Shinn (1937) in work with several hundred mice, found no clear evidence of increased phagocytosis by leucocytes or reticulo-endothelial cells of liver or spleen in drug-treated animals. Long has recently been quoted by Bohhnan (1937) as believing that phagocytosis is neither inhibited nor enhanced by the drug.
The possibility of a direct effect of the drug upon bacteria has attracted considerable attention. Colebrook and his associates (1936) and Long and Bliss (1937 a and b; also Bliss and Long, 1937) have reported a bacteriostatic effect upon streptococci with sulfanilamide in culture media. The failure of Rosenthal (1937) to confirm this was probably due to use of large inocula. The easily demonstrated bacteriostatic action of the drug in vitro, together with the findings of Bliss and Long (1937) in connection with experimental infections in mice, seems to throw the weight of evidence in favor of the theory that the action is directly upon the bacteria themselves rather than an effect upon the usual elements involved in defense. If we accept the view that sulfanilamide acts directly upon bacteria, the question arises as to whether this action is inhibitory or bactericidal (in the sense of sterilization). HeJmholtz and his associates (1937), among others, have reported a bactericidal effect with the drug in certain infections of the urinary tract. This effect in urine has been demonstrated in vitro. A bactericidal effect in blood has been demonstrated by Colebrook and his associates (1936) . This has been confirmed by FinklestoneSayliss (1937) who found that a bactericidal effect was obtained in de-leucocyted blood as well as in whole blood. Osgood and Brownlee (1938) have reported that sulfanilamide in human marrow cultures effects sterilization when streptococci are added, but these investigators do not believe that the drug alone is able to kill the organisms. Gay and Clark (1937) state that the drug "has no bactericidal effect on the streptococcus when added to nutrient media in the test tube." Bliss and Long (1937) have reported experiments which do not support the belief that sulfanilamide has a bactericidal effect in vitro. Nitti and his associates Mayer (1937) , on the other hand, reported experiments in which the drug apparently brought about sterilization in peptone-glucose water and saline, respectively, when small inocula of streptococci were used.
It is evident from the literature cited above that the question as to whether sulfanilamide acts as a bacteriostatic or as a bactericidal agent is still unsettled.
Although test temperatures were not mentioned in every case, it is probable that the above-mentioned investigations on the effectiveness of the drug in vitro have been carried out at approximately 370C. As far as we have been able to determine, the effect of the drug at higher temperatures upon streptococci in vitro seems to have been overlooked. The present report contains preliminary data bearing on the bactericidal action of sulfanilamide upon Beta-hemolytic streptococci in vitro at an elevated test temperature. Experiments designed to evaluate the factors which condition this bactericidal action will form the basis of subsequent reports.
MATERIALS AND METHODS
Strains. With the exception of B-168, all strains used in the present study had been recently isolated from cases at the Childrens Hospital.' These cases included septicemia, meningitis, mastoid, otitis media, peritonitis and scarlet fever infections. Colony variants, determined in accordance with the criteria suggested by Ward and Lyons (1935) , included F, M, C and a fourth variant, not as yet described, which we have tentatively designated as the B variant. B-168 is the "Richards" strain, used by Colebrook and his associates (1936) The flasks were attached in a horizontal position to a wheel which was revolved at 10 R.P.M. in an incubator. As each flask rotated, its contents were continuously spread and rolled over the glass surface, which insured satisfactory mixture throughout the test period. The initial concentration of each test mixture was determined by making a similar mixture and immediately transferring 1.0 cc. through a series of 9 cc. blood broth dilution blanks. The bacterial concentration was expressed as the logarithm10 of the highest dilution of test mixture in blood broth which showed growth after 72 hours incubation at 370C. After incubation of mixtures for test period, bacterial concentrations were again determined by quantitative dilution in tubes of blood broth. Growth in blood broth tubes was checked by loop streaks on blood agar plates.
Criteria for sterility in test mixtures. Test mixtures were considered to be sterile when growth was not obtained in the following subcultures incubated at 370C. for 72 hours: (a) loopful streaked on blood agar plate; (b) blood agar pour plate culture of 0.5 cc. of undiluted test mixture; (c) 1.0 cc. of test mixture added to 9 cc. of PD blood broth.
RESULTS
Preliminary tests had convinced us that a concentration of as much as 100 mgm. per cent sulfanilamide in whole blood, or broth, at 370C. failed to sterilize an inoculum of certain strains of Beta-hemolytic streptococci; when an initial concentration in test mixtures of 1,000 to 10,000 bacteria per cubic centimeter was used.
During the course of some work carried out at the Harvard School of Public Health, a year ago, it was observed that many freshly isolated strains of hemolytic streptococci grew rapidly and abundantly at 40'C. A few trial mixtures of sulfanilamide and streptococci in blood were tested at elevated temperatures and what appeared to be a bactericidal action, due to the drug, was consistently obtained at 400C. with 20 mgm. per cent sulfanilamide in horse blood during 48 hours incubation. The bactericidal effect was not obtained at 370C. These observations led to the present study.
The first part of our work was directed to determine if the bactericidal action noted above was confined to the particular strains used. Accordingly, the bactericidal test technique, described elsewhere in this paper, was used with 36 different strains freshly isolated from various human infections. In all cases, sterilization of the test inoculum, in normal defibrinated horse blood containing 20 mgm. per cent of the drug, was obtained during 48 hours incubation at 400C. Control mixtures, without the drug, simultaneously incubated, showed complete hemolysis of blood and abundant growth of bacteria at the end of the test period. Blood freshly drawn gave the same result as that which had been refrigerated for as long as two weeks.
We have fully appreciated the fact that it is often extremely difficult to distinguish inhibitory and bactericidal action. Subcultures may fail to show growth, not because test mixtures are sterile, but because of continuing inhibition. The strongest concentration of sulfanilamide used in our tests was 20 mgm. per cent. Subcultures made by transferring 1.0 cc. of test mixture into 9 cc. of PD blood broth diluted the test concentration of drug 1:10, or, to 2 mgm. per cent. Therefore, tests were made to determine whether 2, or more, mgm. per cent of sulfanilamide would inhibit a small number of viable bacteria under subculture conditions, i.e., in blood broth incubated at 370C. To one series of PD blood broth blanks sulfanilamide was added to a final concentration of 2.5 mgm. per cent. A culture of streptococci was then diluted in PD broth out to 10-8. The sulfanilamide-blood-broth and a control blood-broth series were then inoculated with the culture dilutions containing decreasing numbers of bacteria and all tubes were incubated at 370C. for 48 hours. In no case did 2.5 mgm. per cent sulfanilamide prevent abundant growth from an inoculum yielding a single colony, as determined by plate counts. Similar tests were made with several different strains. In all cases, the smallest bacterial inoculum grew out equally well, with or without the drug. Moreover, it was found that as much as 20 mgm. per cent sulfanilamide did not prevent the growth of small inocula in PD blood broth at 370C. Additional evidence was obtained by re-inoc-ulating test subculture tubes which appeared to be sterile with a small number of viable bacteria (from 1 to 10 colonies). The growth resulting from this second inoculum was interpreted as meaning that growth would also have resulted from the test mixture inoculum if it had contained any viable bacteria. We believe that the foregoing results justify our assumption that The experiments outlined above showed that a bactericidal effect could be demonstrated with 20 mgm. per cent sulfanilamide under conditions which were otherwise favorable for abundant bacterial growth. However, the method used failed to illuminate the nature of the bactericidal action involved. Therefore, growth curves were plotted to determine the beginning and progress of bactericidal action to the point of sterility.
Growth curve procedure. Mixtures of bacteria and drug in PD broth, similar to those described above, were similarly incubated. 0.2 cc. samples removed at frequent intervals were diluted 1:10 in 1.8 cc. of broth, further quantitative dilution being carried out by transferring 1.0 cc. of this 1:10 dilution through 9 cc. blood broth blanks. 1.0 cc. of at least two dilutions was plated out in blood-agar pour plates.
Results of preliminary growth-curve tests with a large number of mixtures confirmed the observations previously noted. An inhibitory effect, due to sulfanilamide, on all strains tested, was The curves in chart 1 show that growth in the plain broth controls was characterized by multiplication at a rapid rate during the first twelve hours, reaching a growth level which remained practically unchanged up to the thirtieth hour of in- Sulf.-Broth 37 3.6 5.3 5.9 6.2 6.0 5.9 5.9
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Sulf.-Broth 37 3.4 5.0 5.7 6.2 6.6 7.0 7.0 7.0 6.9 Broth 37 3.4 5.3 6.5 7.2 7.9 7.8 7.8 7. cubation. Raising the test temperature to 400C. slowed down the optimal rate of multiplication in plain broth controls. Also, with 3 of the 4 strains, the maximal bacterial concentration at this temperature was at a level slightly lower than that reached at 370C., as may be seen by comparing corresponding curves in charts 1 and 2. The absence of a significant lag period in any (Colebrook et al., 1936; Long and Bliss, 1937 a and b; Bliss and Long, 1937; Finklestone-Sayliss, 1937) have concluded that the drug's action is directly upon the bacteria, but there has been incomplete agreement as to whether this action is truly bactericidal or merely inhibitory in nature. Our studies have been in connection with the effect of sulfanilamide in vitro only. Under these conditions, we believe that the effect obtained with the drug, on hemolytic streptococci, will depend principally upon the temperature at which the test is run.
The fact that bactericidal action had been observed with the drug in whole blood at 400C., when only inhibition could be demonstrated at 370C., led us to conclude that the temperature at which bacteria were subjected to action of the drug determined whether sterilization or inhibition would result. However, we realize that it is difficult to draw definite conclusions from results with a test mixture which contains not only drug and bacteria, but leucocytes and serum as well.
In plain PD broth, on the other hand, it seems to us that there can be no question of bactericidal action on the part of any element other than the drug itself. With such a mixture we are obviously dealing only with bacteria multiplying in an environment which includes nutritive elements, metabolites and drug. Under these conditions, it appears that temperature is the determining factor. Although we have repeatedly verified our bactericidal results at 40'C., we have, thus far, been unable to obtain data which will explain just why the streptococci are killed by the drug at 40'C. when they are merely inhibited at 370C. under conditions otherwise similar.
The significance of a bactericidal action with sulfanilamide at 400C. in vitro should not be overlooked. Bactericidal action with this drug has been demonstrated by us only at elevated temperatures corresponding to those associated with high fevers. This suggests a correlation with successful clinical treatment of patients with severe hemolytic streptococcus infections involving high temperatures. Hence, in rapidly successful sulfanilamide therapeusis, it may be that the invading bacteria have been exposed, at times, to the action of the drug at temperatures 4-96 on September 13, 2017 by guest http://jb.asm.org/ Downloaded from similar to those at which bactericidal action has been demonstrated in vitro. As far as we have been able to determine, there has been but one report on the combined use of hyperthermotherapy and sulfanilamide. Ballenger, Elder and McDonald (1937) , in a clinical note have reported successful treatment of a few cases of gonococcic infection with the administration of an artificial fever of 1030 to 104'F. combined with sulfanilamide. It is, perhaps, significant that patients chosen for this combined treatment were those who had failed to respond to either treatment alone.
The significance of our observations in connection with making comparative tests on sulfanilamide and related compounds, in vitro, is obvious.
CONCLUSIONS
Bactericidal action upon thirty-six strains of Beta-hemolytic streptococcus recently isolated from human infections has been demonstrated with 20 mgm. per cent sulfanilamide in vitro at 400C. in peptone-glucose broth and in whole blood. Preliminary results indicate that this streptococcidal action can be demonstrated in vitro with lower concentrations of sulfanilamide.
Under our experimental conditions, bactericidal action due to sulfanilamide could not be demonstrated at test temperatures lower than 390C.
Experimental evidence indicates that the action of sulfanilamide in vitro is delayed for at least three hours.
